Bausch + Lomb shakes up executive team

Eye health company Bausch + Lomb has expanded its executive team, adding Bob Bailey as its executive vice president and chief legal officer and Andrew Stewart as its president of ophthalmic pharmaceuticals. 

Advertisement

Christina Ackermann will step down from the roles of general counsel and president of ophthalmic pharmaceuticals and leave Bausch + Lomb on April 28, according to an April 12 press release. 

Mr. Bailey previously served at Bausch + Lomb for 18 years earlier in his career. He and Mr. Stewart, who most recently served as general manager of AbbVie’s eye care franchise, both have more than 25 years of experience in the healthcare industry. 

Advertisement

Next Up in Ophthalmology

  • Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

  • Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

Advertisement

Comments are closed.